The novel and potent CD40 agonist KHK2840 augments the antitumor efficacy of anti-PD-1 antibody and paclitaxel
Kobayashi, Chiaki, Suzuki-Imaizumi, Minami, Sakaguchi, Yasuko, Ishii, Toshihiko, Adachi, Maiko, Kaneda, Ayumi, Ebihara, Ritsuko, Saito, Masato, Uemori, Takeshi, Mori, Kiyotoshi
Published in Cancer science (08.10.2024)
Published in Cancer science (08.10.2024)
Get full text
Journal Article